CASR and secondary hyperparathyroidism: It should, however, be emphasized that experimental secondary hyperparathyroidism does not fully resemble the advanced hyperparathyroidism with clonal transformation which is seen in humans, and it can therefore not be ruled out that CaR or VDR promoter methylation might exist in the human setting.